No Data
No Data
Express News | MaxCyte Signs License Agreement With Legend Biotech, Under Which Legend Obtains Non-Exclusive Worldwide License To Use MaxCyte's Flow Electroporation And ExPERT Platform; MaxCyte Eligible For Fees And Miletones
Express News | MaxCyte Inc - Upon Successful Commercialization, Is Eligible to Receive Licensing Fees and Royalties on Net Sales of Licensed Products
Express News | MaxCyte Inc - Will Be Eligible to Receive Annual Licensing Fees and Milestones From Legend Biotech During Clinical Development
Express News | MaxCyte Inc - Under Terms, Legend Biotech Obtains a Non-Exclusive Worldwide License to Use Co's Flow Electroporation Technology and Expert Platform
Express News | MaxCyte, Inc. MaxCyte, Inc. - Mxcr - Signing of Strategic Platform License
Express News | MaxCyte Signs Strategic Platform License Agreement With Legend Biotech to Accelerate Cell Therapy Discovery and Development
No Data